
浏览全部资源
扫码关注微信
1.610031 成都,西南交通大学医学院
2.400038 重庆,陆军军医大学(第三军医大学)第一附属医院消化内科,胆汁淤积肝病中心和代谢性肝病中心
3.610083 成都,西部战区总医院消化内科
[柴进,E-mail: jin.chai@cldcsw.orgCHAI Jin, E-mail: jin.chai@cldcsw.org
[吴晓玲,E-mail:wxllady@163.comWU Xiaoling, E-mail: wxllady@163.com
收稿:2023-04-26,
修回:2023-06-01,
纸质出版:2023-09-30
移动端阅览
张孟妮, 张晓珣, 欧阳佳凤, 等. 基于转录组测序对胆汁酸诱导肝细胞反应的Hub基因的筛选及验证[J]. 陆军军医大学学报, 2023,45(18):1883-1893.
Mengni ZHANG, Xiaoxun ZHANG, Jiafeng OUYANG, et al. Screening and validation of Hub genes in bile acid-induced hepatocyte response based on transcriptome sequencing[J]. Journal of Army Medical University, 2023, 45(18): 1883-1893.
张孟妮, 张晓珣, 欧阳佳凤, 等. 基于转录组测序对胆汁酸诱导肝细胞反应的Hub基因的筛选及验证[J]. 陆军军医大学学报, 2023,45(18):1883-1893. DOI: 10.16016/j.2097-0927.202303158.
Mengni ZHANG, Xiaoxun ZHANG, Jiafeng OUYANG, et al. Screening and validation of Hub genes in bile acid-induced hepatocyte response based on transcriptome sequencing[J]. Journal of Army Medical University, 2023, 45(18): 1883-1893. DOI: 10.16016/j.2097-0927.202303158.
目的
2
通过转录组测序分析结合型胆汁酸诱导肝细胞的基因表达情况,筛选和验证结合型胆汁酸诱导肝细胞代谢的Hub基因。
方法
2
使用牛磺胆酸(taurocholate acid,TCA)处理野生型小鼠的原代肝细胞,转录组测序(RNA sequencing
RNA-Seq)检测经TCA诱导后肝细胞的基因表达情况,将Fold Change≥1.5且
P
<
0.05作为筛选标准获取差异表达基因(differentially expressed genes
DEGs)并进行生物信息学分析。使用STRING(search tool for the retrieval of interesting genes)数据库建立DEGs的蛋白质-蛋白质互作网络(protein-protein interaction,PPI),基于PPI网络利用Cytoscape软件找寻Hub基因。利用实时荧光定量PCR(RT-qPCR)在体内外水平对目标Hub基因进行验证,使用蛋白质免疫印迹试验检测肝细胞内PSAT1/AKT/GSK3β信号通路相关蛋白的表达,使用糖原检测试剂盒检测肝细胞和肝组织糖原水平。
结果
2
TCA处理小鼠原代肝细胞共有差异基因293个,其中上调基因122个,下调基因171个。基因本体(Gene Ontology
GO)功能富集分析、京都基因与基因百科全书(Kyoto Encyclopedia of Genes and Genomes,KEGG)通路富集分析及基因集富集分析(Gene Set Enrichment Analysis,GSEA)的
结果
2
显示,DEGs主要富集在代谢、炎症、肿瘤等通路。使用Cytohubba插件得到16个Hub基因,包括
Ccnd
1、
Ppara
、
Irs
1、
Ccl
2、
Ddit
3、
Serpine
1、
Nr
0
b
2、
Atf
3、
Phgdh
、
Trib
3、
Lepr
、
G
6
pc
、
Psat
1、
Cxcl
2、
Asns
、
Fgf
21。RT-qPCR检测
结果
2
显示,多种结合型胆汁酸包括TCA、甘氨鹅去氧胆酸(glycochenodeoxycholic acid
GCDCA)、甘氨胆酸(glycocholic acid hydrate
GCA)均能诱导小鼠原代肝细胞内
Psat
1 mRNA表达水平增高(
P
<0.05)。此外,胆管结扎(bile duct ligation
BDL)胆汁淤积小鼠肝脏中的
Psat
1 mRNA水平增高(
P
<0.05)。Western blot检测结果显示,TCA能够诱导肝细胞内
Psat
1表达及激活AKT/GSK3β信号通路。TCA能够诱导小鼠原代肝细胞糖原合成增加,与BDL小鼠模型肝组织糖原合成增加以及血糖水平降低的结果一致(
P
<0.05)。
结论
2
Psat
1可能是胆汁酸影响肝细胞糖代谢的相关基因,其高水平表达可能与肝细胞糖代谢的改变有关。
Objective
2
To screen and verify the Hub genes involved in conjugated bile acid-induced hepatocyte metabolism through transcriptome sequencing analysis.
Methods
2
Primary mouse hepatocytes were treated with taurocholic acid (TCA)
and the gene expression of TCA-induced hepatocytes was detected by RNA-Seq analysis. Differential expression genes (DEGs) were identified using a fold change ≥1.5 and
P
value
<
0.05 as the screening criteria. The protein-protein interaction (PPI) network of DEGs was constructed using the STRING database
and Hub genes were screened using Cytoscape software based on the PPI network. Real-time qPCR was used to validate the identified Hub gene
in
vitro
and
in
vivo
. Western blotting was employed to detect the expression of proteins related to PSAT1/AKT/GSK3β signaling pathway. The glycogen level in the hepatocytes and liver tissues were detected using glycogen dete
ction kit.
Results
2
RNA-Seq analysis identified 293 DEGs in primary mouse hepatocytes upon TCA treatment
including 122 up-regulated genes and 171 down-regulated genes. Gene Ontology (GO) analysis
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis
and Gene Set Enrichment Analysis (GSEA) revealed that these DEGs were mainly enriched in metabolism
inflammatory and tumorigenic pathways. Cytohubba plugin identified 16 Hub genes
including
Ccnd
1
Ppara
Irs
1
Ccl
2
Ddit
3
Serpine
1
Nr
0
b
2
Atf
3
Phgdh
Trib
3
Lepr
G
6
pc
Psat
1
Cxcl
2
Asns
and
Fgf
21. RT-qPCR results demonstrated that various conjugated bile acids
glycocholic acid (GCA)
glycochenodeoxycholic acid (GCDCA)
and TCA can induce a significant increase in
Psat
1 mRNA level in primary mouse hepatocytes (
P
<
0.05).
In
vivo
experiments also showed that the mRNA level of
Psat
1 was increased significantly in the liver tissues of mouse cholestatic model induced by bile duct ligation (BDL) when compared to the control group (
P
<
0.05). Western blotting indicated that TCA treatment induced the expression of
Psat
1 and activation of AKT/GSK3β signaling pathway in primary mouse hepatocytes. TCA treatment also resulted in an increase in glycogen synthesis in primary mouse hepatocytes
which was consistent with an increase in glycogen synthesis in the liver tissue and a decrease in blood glucose level in the mouse model established with BDL (
P
<
0.05).
Conclusion
2
Psat
1 may be a gene involved in alteration of
glucose metabolism induced by bile acid
and its high expression may be associated with these changes in glucose metabolism in hepatocytes.
CAI S Y, YU D, SOROKA C J, et al . Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis[J ] . J Hepatol, 2021, 74(3): 550-559. DOI: 10.1016/j.jhep.2020.09.035..
RAMM G A, SHEPHERD R W, HOSKINS A C, et al . Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment[J ] . Hepatology, 2009, 49(2): 533-544. DOI: 10.1002/hep.22637..
CAMPISI J, D'ADDA DI FAGAGNA F. Cellular senescence: when bad things happen to good cells[J]. Nat Rev Mol Cell Biol, 2007, 8(9): 729-740. DOI: 10.1038/nrm2233.
SHAPIRO H, KOLODZIEJCZYK A A, HALSTUCH D, et al . Bile acids in glucose metabolism in health and disease[J ] . J Exp Med, 2018, 215(2): 383-396. DOI: 10.1084/jem.20171965..
胡晗, 田彩云, 张国远, 等. 肝源性糖尿病发病机制的最新进展[J]. 临床肝胆病杂志, 2021, 37(2): 429-432. DOI: 10.3969/j.issn.1001-5256.2021.02.038.
HU H, TIAN C Y, ZHANG G Y, et al . Latest advances in the pathogenesis of hepatogenous diabetes[J ] . J Clin Hepatol, 2021, 37(2): 429-432. DOI: 10.3969/j.issn.1001-5256.2021.02.038..
田彩云, 胡晗, 张国远, 等. 糖代谢紊乱对肝硬化相关并发症的影响[J]. 临床肝胆病杂志, 2021, 37(5): 1197-1200. DOI: 10.3969/j.issn.1001-5256.2021.05.046.
TIAN C Y, HU H, ZHANG G Y, et al . Influence of glucose metabolism disorder on complications associated with liver cirrhosis[J ] . J Clin Hepatol, 2021, 37(5): 1197-1200. DOI: 10.3969/j.issn.1001-5256.2021.05.046..
STARK R, GRZELAK M, HADFIELD J. RNA sequencing: the teenage years[J]. Nat Rev Genet, 2019, 20(11): 631-656. DOI: 10.1038/s41576-019-0150-2.
LI M, CAI S Y, BOYER J L. Mechanisms of bile acid mediated inflammation in the liver[J]. Mol Aspects Med, 2017, 56: 45-53. DOI: 10.1016/j.mam.2017.06.001.
FICKERT P, WAGNER M. Biliary bile acids in hepatobiliary injury-What is the link?[J]. J Hepatol, 2017, 67(3): 619-631. DOI: 10.1016/j.jhep.2017.04.026.
HOOGERLAND J A, LEI Y, WOLTERS J C, et al . Glucose-6-phosphate regulates hepatic bile acid synthesis in mice[J ] . Hepatology, 2019, 70(6): 2171-2184. DOI: 10.1002/hep.30778..
ALVARO D, METALLI V D, ALPINI G, et al . The intrahepatic biliary epithelium is a target of the growth hormone/insulin-like growth factor 1 axis[J ] . J Hepatol, 2005, 43(5): 875-883. DOI: 10.1016/j.jhep.2005.04.011..
VAN NOORDEN C J, DÖPP E A, DIJKSTRA C D, et al . Reduction in phosphoenolpyruvate carboxykinase in rat liver parenchymal cells following experimentally induced cholestasis[J ] . Virchows Arch B Cell Pathol Incl Mol Pathol, 1988, 54(4): 252-255. DOI: 10.1007/bf02899219..
ZHENG T, YANG X, LI W, et al . Salidroside attenuates high-fat diet-induced nonalcoholic fatty liver disease via AMPK-dependent TXNIP/NLRP3 pathway[J ] . Oxid Med Cell Longev, 2018, 2018: 8597897. DOI: 10.1155/2018/8597897..
KATSUMURA S, SIDDIQUI N, GOLDSMITH M R, et al . Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure[J ] . Cell Metab, 2022, 34(4): 564-580. e8. DOI: 10.1016/j.cmet.2022.03.005..
WEI L, LEE D, LAW C T, et al . Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC[J ] . Nat Commun, 2019, 10(1): 4681. DOI: 10.1038/s41467-019-12606-7..
WANG X J, LI F F, ZHANG Y J, et al . TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis[J ] . Cancer Biomark, 2020, 29(3): 307-315. DOI: 10.3233/cbm-201577..
LI H, NING S, GHANDI M, et al . The landscape of cancer cell line metabolism[J ] . Nat Med, 2019, 25(5): 850-860. DOI: 10.1038/s41591-019-0404-8..
YOSHⅡ D, SHIMATA K, YOKOUCHI Y, et al . SOX9 contributes to the progression of ductular reaction for the protection from chronic liver injury[J ] . Hum Cell, 2022, 35(2): 721-734. DOI: 10.1007/s13577-022-00683-8..
FAN J, SHEN H, SUN Y, et al . Bone morphogenetic protein 4 mediates bile duct ligation induced liver fibrosis through activation of Smad1 and ERK1/2 in rat hepatic stellate cells[J ] . J Cell Physiol, 2006, 207(2 ): 499-505. DOI: 10.1002/jcp.20593..
DAI M, HUA H, LIN H, et al . Targeted metabolomics reveals a protective role for basal PPAR α in cholestasis induced by α -naphthylisothiocyanate[J ] . J Proteome Res, 2018, 17(4): 1500-1508. DOI: 10.1021/acs.jproteome.7b00838..
WANG H, VOHRA B P, ZHANG Y, et al . Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice[J ] . Hepatology, 2005, 42(5): 1099-108. DOI: 10.1002/hep.20903..
XU Y, LI Y, JADHAV K, et al . Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism[J ] . Nat Metab, 2021, 3(1): 59-74. DOI: 10.1038/s42255-020-00331-1..
WANG P, YANG Y, PANG G, et al . Hepatocyte-derived MANF is protective forrifampicin-induced cholestatic hepatic injury via inhibiting ATF4-CHOP signal activation[J ] . Free Radic Biol Med, 2021, 162: 283-297. DOI: 10.1016/j.freeradbiomed.2020.10.028..
LEFEBVRE P, CARIOU B, LIEN F, et al . Role of bile acids and bile acid receptors in metabolic regulation[J ] . Physiol Rev, 2009, 89(1): 147-191. DOI: 10.1152/ph ysrev.00010.2008..
GAO F, ZHANG X, ZHOU L, et al . Type 2 diabetes mitigation in the diabetic Goto-Kakizaki rat by elevated bile acids following a common-bile-duct surgery[J ] . Metabolism, 2016, 65(2): 78-88. DOI: 10.1016/j.metabol.2015.09.014..
CHO H, MU J, KIM J K, et al . Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta)[J ] . Science, 2001, 292(5522): 1728-1731. DOI: 10.1126/science.292.5522.1728..
CROSS D A, ALESSI D R, COHEN P, et al . Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B[J ] . Nature, 1995, 378(6559): 785-789. DOI: 10.1038/378785a0..
SALTIEL A R. Insulin signaling in the control of glucose and lipid homeostasis[J]. Handb Exp Pharmacol, 2016, 233: 51-71. DOI: 10.1007/164_2015_14.
JIA L, LI D, WANG Y N, et al . PSAT1 positively regulates the osteogenic lineage differentiation of periodontal ligament stem cells through the ATF4/PSAT1/Akt/GSK3β/β-catenin axis[J ] . J Transl Med, 2023, 21(1): 70. DOI: 10.1186/s12967-022-03775-z..
DUAN W, LIU X. PSAT1 Upregulation contributes to cell growth and cisplatin resistance in cervical cancer cells via regulating PI3K/AKT signaling pathway[J ] . Ann Clin Lab Sci, 2020, 50(4): 512-518.
FANG Y, LIANG X, XU J, et al . MiR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer[J ] . Cancer Manag Res, 2018, 10: 6537-6547. DOI: 10.2147/cmar.S185789..
GUO Z F, KONG F L. Akt regulates RSK2 to alter phosphorylation level of H2A. X in breast cancer[J]. Oncol Lett, 2021, 21(3): 187. DOI: 10.3892/ol.2021.12448.
YU J, XIAO F, GUO Y, et al . Hepatic phosphoserine aminotransferase 1 regulates insulin sensitivity in mice via tribbles homolog 3[J ] . Diabetes, 2015, 64(5): 1591-602. DOI: 10.2337/db14-1368..
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621